Newbridge Financial Services Group’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.32K | Buy |
829
+529
| +176% | +$5.95K | ﹤0.01% | 909 |
|
|
2025
Q1 | $1.71K | Hold |
300
| – | – | ﹤0.01% | 905 |
|
|
2024
Q4 | $2.95K | Hold |
300
| – | – | ﹤0.01% | 929 |
|
|
2024
Q3 | $2.45K | Hold |
300
| – | – | ﹤0.01% | 547 |
|
|
2024
Q2 | $4.01K | Sell |
300
-50
| -14% | -$669 | ﹤0.01% | 878 |
|
|
2024
Q1 | $16.2K | Buy |
350
+300
| +600% | +$13.9K | 0.01% | 648 |
|
|
2023
Q4 | $3.38K | Hold |
50
| – | – | ﹤0.01% | 908 |
|
|
2023
Q3 | $3.62K | Sell |
50
-175
| -78% | -$12.7K | ﹤0.01% | 1000 |
|
|
2023
Q2 | $16.7K | Sell |
225
-25
| -10% | -$1.86K | 0.01% | 746 |
|
|
2023
Q1 | $13.3K | Buy |
250
+225
| +900% | +$12K | 0.01% | 850 |
|
|
2022
Q4 | $1.69K | Hold |
25
| – | – | ﹤0.01% | 1244 |
|
|
2022
Q3 | $3K | Hold |
25
| – | – | ﹤0.01% | 1124 |
|
|
2022
Q2 | $2K | Sell |
25
-69
| -73% | -$5.52K | ﹤0.01% | 1168 |
|
|
2022
Q1 | $15K | Buy |
94
+69
| +276% | +$11K | 0.01% | 804 |
|
|
2021
Q4 | $8K | Sell |
25
-13
| -34% | -$4.16K | ﹤0.01% | 964 |
|
|
2021
Q3 | $17K | Buy |
+38
| New | +$17K | 0.01% | 710 |
|